Alpha-1 adrenergic receptor antagonist and 5-alpha-reductase inhibitor

This page covers all Alpha-1 adrenergic receptor antagonist and 5-alpha-reductase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Alpha-1 adrenergic receptor and 5-alpha-reductase.

Targets

Alpha-1 adrenergic receptor and 5-alpha-reductase

Phase 3 pipeline (1)

• tamsulosin and/or dutasteride · Case Comprehensive Cancer Center · Urology
  Tamsulosin and dutasteride are alpha-1 adrenergic receptor antagonists and 5-alpha-reductase inhibitors, respectively, used to treat benign prostatic hyperplasia (BPH) symptoms and reduce the risk of acute urinary retention and BPH-related surgery.

Patent intelligence

• alpha 1 adrenergic receptor antagonist and 5 alpha reductase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates